Growth investing asks you to do something that feels fundamentally reckless: pay a premium for a business based on what it might become, not what it is today. You're not buying at a discount. You're buying at a price that assumes the future looks roughly like your best guess - and accepting that when you're wrong, the consequences are immediate and expensive. The stock doesn't gently decline. It craters. Because the premium you paid was for a future that just got repriced to zero.
And yet. The greatest wealth creation stories of the past three decades belong overwhelmingly to growth investors. The people who owned Amazon in 2001 when it nearly went bankrupt. Apple in 2003 when it was "that niche computer company." Nvidia in 2015 when it was a gaming chip maker that nobody outside of PC enthusiasts cared about. Those investors weren't geniuses. They understood what they owned, and they held when everyone else was selling. The crowd saw broken tech stocks. Growth investors saw the early innings of platforms that would eventually reshape entire industries. Same stocks, same prices, radically different time horizons - radically different outcomes.
This piece walks through the framework those investors used. How to tell a genuine secular growth story from a cyclical revenue spike. How to figure out whether the price makes sense for the growth you're getting. How to build a portfolio that captures compounding without concentrating so much risk in one name that a single blowup erases years of gains. And maybe most importantly - how to hold through the violent drawdowns that are not a risk of growth investing but an inherent, unavoidable feature of it.
The Logic of Growth Investing
Growth and value aren't opposites. They're different bets on where the market is wrong. Value says the price is too low for what the business is worth today. Growth says the price is too low for what the business will be worth in five years. Both can be right. Both can be catastrophically wrong.
So what qualifies as a growth stock? Most practitioners use a simple threshold: revenue growing at 15%+ per year, sustained over multiple years, for a structural reason that's likely to continue. That word "structural" is doing a lot of heavy lifting. A mining company whose revenue spiked because copper prices doubled isn't a growth stock - that's a commodity cycle. A retailer that grew 20% because it opened new stores it can't profitably fill isn't growing - it's burning cash with better optics. Real growth comes from expanding markets, increasing adoption rates, network effects, or product innovation that compounds over time. It's baked into the business model, not driven by one-time tailwinds.
The profit mechanism is fundamentally different from value investing, and this matters. A value investor buys a $60 stock they think is worth $100, then waits for the gap to close. The intrinsic value stays roughly static - you're collecting the discount. Growth investors profit because intrinsic value itself is moving upward. Buy a company at $10 whose earnings are compounding at 25% annually, and in eight years that business is worth roughly $57. The starting valuation that looked absurdly expensive? It becomes irrelevant when the earnings underneath it have grown sevenfold. That's the entire magic trick of growth investing - time transforms an apparently expensive entry point into a bargain.
Why growth stocks rarely pay dividends. This trips up a lot of beginners. "Where's my income?" The answer: it's being reinvested at 20-30% annual returns inside the company. If a business can compound capital internally at 25%, paying you a 2% dividend is genuinely dumb capital allocation - they'd be sending you money that would earn far less in your hands than it would inside their growth engine. Apple didn't pay a dividend until 2012. Amazon still doesn't. The income comes later, when the growth phase matures and reinvestment opportunities narrow. Asking a hyper-growth company to pay dividends is like withdrawing money from a compounding account at the peak of its growth curve.
Offensive vs defensive. Growth investing thrives in bull markets, loose monetary policy, and periods when investors are comfortable taking risk. In bear markets? Growth stocks get destroyed. It's not random - it's math. When interest rates rise, the discount rate applied to future cash flows goes up, and companies whose value is concentrated in earnings 5-10 years out lose more present value than companies generating cash today. The 2022 rate hike cycle demonstrated this with surgical precision: the Nasdaq dropped 33% while dividend utilities barely flinched. This isn't a design flaw. It's the price tag for the upside, and you need to build it into your plan from day one.
Five Characteristics of a True Growth Stock
Plenty of companies grow fast. Most of them aren't good investments. The distinction between a real compounding machine and a company riding a one-time wave comes down to five things.
Five Metrics That Identify Real Growth
Talk is cheap. Investor presentations are cheaper. These five metrics, tracked over time and read together, cut through the narrative and tell you whether a company's growth is real, sustainable, and reasonably priced - or just marketing with a stock ticker.
Where Growth Lives: Sectors Driving the Next Decade
Growth stocks don't appear randomly. They cluster where innovation is disrupting incumbents, where adoption curves are still in their early chapters, and where the demand drivers are structural - not dependent on one good quarter or a lucky commodity cycle.
AI and Semiconductor Infrastructure. The current AI build-out is arguably the largest industrial capital cycle since the original internet infrastructure wave - except this time, the enabling companies are generating massive real cash flows from day one, not burning through venture capital on eyeball counts. The supply chain runs from ASML (the only company on earth making the machines that make advanced chips) through TSMC (fabrication) to Nvidia (AI accelerators) to the hyperscale cloud platforms spending tens of billions annually on data centers. And the demand loop compounds on itself: more AI capability drives more data collection, which drives more computing demand, which drives more chip orders. Companies across every layer of this stack have multi-year visibility on committed customer spend. That's unusual. Most growth stories depend on hope. This one has signed purchase orders.
Healthcare, GLP-1 Drugs, and Precision Medicine. Demographics are destiny. Aging populations across the US, Europe, Japan, and China create expanding healthcare demand that doesn't care what the Fed does with interest rates. Then you add GLP-1 drugs - Ozempic, Mounjaro, Wegovy - which have opened a therapeutic category addressing obesity, type-2 diabetes, and cardiovascular risk in a market analysts project at $100B+ annually by 2030. That's not a niche. That's a market bigger than most countries' GDP. Separately, AI-assisted drug discovery is compressing timelines from years to months. Healthcare growth is unusual because its tailwinds are almost entirely demographic and scientific - it's one of the few sectors genuinely immune to most macro cycles.
Clean Energy Transition. Regardless of what any politician says next week, the money is already committed. The Inflation Reduction Act. The European Green Deal. China's dominance in solar manufacturing and battery production. Government-mandated capital allocation into grid modernization, battery storage, and EV infrastructure has turned clean energy into a multi-decade growth category backed by regulation, economics, and physics. The global addressable market for clean energy infrastructure is measured in trillions. You don't have to be a climate activist to see the investment opportunity - you just have to follow the capital expenditure commitments.
Digital Finance and Embedded Payments. If you live in the US or Northern Europe, it's easy to think the fintech revolution is over. It isn't. In Southeast Asia, Africa, and Latin America, the migration from cash to digital payments is still in its early innings. Billions of people lack basic financial services - payments, savings accounts, micro-loans, insurance - that we take for granted. Companies building financial infrastructure in these markets ride two tailwinds simultaneously: expanding middle classes generating more economic activity, and the secular shift from physical cash to digital rails. The addressable market is enormous and largely uncaptured.
Growth vs Value vs Income: A Clear-Eyed Comparison
Anyone who tells you one strategy is always best is selling something. Each approach has a climate where it shines and a climate where it gets destroyed. Knowing the difference is how you blend them instead of picking one and praying.
| Dimension | Growth | Value | Income |
|---|---|---|---|
| Profit mechanism | Intrinsic value compounds upward; sell at a higher multiple of higher earnings | Price converges toward a static intrinsic value; collect the discount | Dividends received over time; price stability secondary |
| Typical starting valuation | High P/E (20–60×); premium for expected growth | Low P/E, P/B (<15×, <1.5×); discount to intrinsic value | Moderate P/E (12–18×); priced for stability and yield |
| Income during holding | Minimal or none; total return comes from price appreciation | Variable; some value companies pay dividends, others don't | High and regular; 3–6% dividend yield is the primary return driver |
| Optimal holding period | 5–15 years; compounding needs time to outweigh starting valuation | 2–5 years; catalyst for re-rating usually materialises in that window | Indefinite; designed for long-term income generation |
| Bear market behaviour | Falls hard (−30% to −60%); long-duration cash flows repriced at higher discount rates | Falls less; already discounted, and assets provide floor | Falls moderately; dividend yield becomes more attractive as price drops |
| Best market climate | Bull markets, low interest rates, high risk appetite, technological disruption cycles | Post-crash recoveries, neglected sectors, rotation away from expensive growth | Any climate; particularly valuable in recessions and high-inflation environments |
| Key risk | Overpaying for growth that doesn't materialise; competition eroding moat | Value trap - business declines rather than re-rating to fair value | Dividend cut; earnings deterioration destroying the yield basis |
| Example companies | Nvidia, Microsoft, Amazon, Shopify, ASML | Berkshire Hathaway, Fairfax Financial, deep-discount Asian small-caps | Realty Income, Johnson & Johnson, LVMH, infrastructure REITs |
The Risk Landscape of Growth Investing
You don't get the higher returns of growth investing without the higher risks. That's the deal. Here are the four ways growth investments most commonly blow up - and each one has claimed portfolios that thought they were being careful.
Bear Markets, Drawdowns, and the Patience Required
The hardest part of growth investing isn't the analysis. It's the 3 AM feeling when your best position is down 45% and every headline confirms you were an idiot for buying it.
In bear markets - especially rate-hike-driven ones - growth stocks don't just fall. They get obliterated. And it's not random. A company whose value is concentrated in earnings 5-10 years from now is mathematically more sensitive to discount rate changes than a utility generating predictable cash today. When the Fed raised rates from 0% to 5% in 2022-2023, the Nasdaq dropped 33%. But individual high-multiple growth names? 50-80% drawdowns were common. Zoom, Peloton, Shopify, PayPal - all down 60-80% from their highs. This isn't bad luck. It's the predictable consequence of applying a higher discount rate to long-duration cash flows. If you own growth, this will happen to you. Not might. Will.
Here's the math that makes drawdowns so treacherous. A 50% decline needs a 100% gain just to get back to even. A 70% decline? You need a 233% gain. A stock that falls 70% and then rallies 100% - which sounds amazing - is still down 40% from where it started. This asymmetry is why position sizing isn't a nice-to-have in growth investing. It's existential. A single name that falls 80% and never recovers isn't some freak accident - it's a documented, repeating pattern at every market peak in living memory. Cisco in 2000. Sun Microsystems. Pets.com. More recently, Peloton.
The practical implication is that you need to make your decision before the drawdown, not during it. Once your growth stock is down 40%, the news will be uniformly terrible, the analysts will have slashed their targets, and every seemingly rational voice will be explaining why the thesis is broken. In that moment, the investor who hasn't done the deep work will sell - because the pain is real and the case for selling is everywhere. The investor who truly understands the business, who knows why the long-term thesis still holds despite the short-term carnage, will hold. Or add. That divergence, compounded over a decade, is the entire ballgame.
Four Strategies for Growth Investors
"Growth investing" isn't one strategy - it's a family of approaches with very different risk profiles, time commitments, and ideal conditions. Here are four, with the honest trade-offs nobody puts in the marketing material.
The quality-filtered approach developed by Peter Lynch. Screen for companies with high historical EPS growth (15%+), strong ROE (20%+), low debt, and PEG ratios below 1.5. Buy when PEG is at or below 1.0. The discipline is to only pay for growth that is demonstrably real and to reject businesses trading at 3–5× PEG regardless of the narrative. GARP investors accept lower peak returns than pure growth investors in exchange for a more conservative valuation anchor and a lower probability of catastrophic loss if growth disappoints.
Best for: Investors who want growth exposure with valuation guardrails. Requires moderate analytical effort - financial statements plus earnings history.
Focus on one or two high-conviction growth sectors - typically technology plus healthcare, or AI infrastructure plus clean energy - and own the five to eight highest-quality businesses in each. This approach allows deep analytical expertise to develop over time: the investor understands the competitive dynamics, the regulatory environment, the key metrics, and the supplier/customer relationships in their chosen sectors at a level that generates genuine informational edge. The risk is concentrated sector exposure - if your sector underperforms a cycle, your portfolio underperforms by more than a diversified approach.
Best for: Investors with sector expertise or strong curiosity in a specific industry. Requires sustained research commitment and tolerance for periods of sector underperformance.
Deliberately seek companies with market capitalisations below $1B that are growing revenues rapidly in expanding markets but are too small to attract institutional coverage. The analytical neglect creates persistent mispricings: great businesses consistently undervalued because no analyst covers them and no fund can own them in size. The expected return premium over large-cap growth is real and well-documented historically - but so is the volatility premium. Individual small-cap growth stocks can go to zero. Diversification across 15–25 names is essential to allow the statistical advantage to overcome individual company failure rates.
Best for: Investors with significant time for research and high risk tolerance. The payoff for getting it right is exceptional; the cost of concentrated failure is severe.
For investors who accept that they cannot reliably outperform professional stock pickers, growth ETFs (iShares MSCI World Momentum, Vanguard Growth, ARK Innovation) provide systematic exposure to the growth factor across hundreds of companies with minimal time commitment. The trade-off is giving up the potential for dramatic outperformance (a single 10-bagger transforms a concentrated portfolio; it barely moves a 200-stock ETF) in exchange for broad participation in the secular growth asset class with low fees and automatic rebalancing. For most investors managing growth as one component of a larger portfolio, this is the most practical approach.
Best for: Time-constrained investors who want growth factor exposure without stock selection. Accepts market-like returns within the growth universe rather than seeking individual stock alpha.
Building and Managing Your Growth Portfolio
Position sizing, diversification, and when to sell work differently in a growth portfolio than most people expect. Some of the rules are genuinely counterintuitive.
Starting allocation. How much growth exposure you take depends on one honest question: if the growth portion of your portfolio dropped 50% tomorrow and took 3 years to recover, would you be okay? Not in theory. Actually okay - not forced to sell, not unable to pay rent, not losing sleep every night. An investor with 20+ years ahead and a stable income can comfortably hold 60-80% growth because time heals drawdowns. Someone 5-7 years from needing the money should cap it at 30-40%. Being forced to liquidate growth positions at the bottom to fund expenses is one of the most wealth-destructive things that can happen to a portfolio.
Diversification within growth. Minimum 10-15 positions across at least three sectors. I know concentration sounds sexier. But single-sector growth portfolios amplify an already volatile strategy into something that can genuinely wipe you out. The 2022 rate shock hit all growth stocks, but it particularly annihilated unprofitable tech. If your entire portfolio was SaaS names with no earnings, you were down 60-70%. Three or more sectors ensures that a structural downturn in one area doesn't impair everything. Keep any single position to 5-8% max on entry - meaningful enough to matter, small enough that a blowup doesn't do permanent damage.
Adding to winners vs. cutting losers. This one is genuinely counterintuitive and I think it's one of the most important lessons in growth investing: your best outcomes come from adding to positions that are working. Not averaging down into things that are falling. A growth stock consistently missing its own revenue targets is telling you something. Listen. The thesis is wrong. Cut it. But a stock that's beating guidance while dropping because the broad market is in a downturn? That's often the best possible time to add. The judgment call between "falling because the market is wrong" and "falling because the business is disappointing" is the single most important skill in managing a growth portfolio. Get this distinction wrong and you'll pour money into dying positions while trimming your future winners.
When to sell. Growth investors are terrible at selling, mostly because the bias toward "just hold" is correct 80% of the time but catastrophically wrong the other 20%. Three sell signals I take seriously: (1) growth has structurally decelerated - not one bad quarter, but two or three consecutive quarters of slowing revenue growth with no good explanation; (2) the competitive moat is visibly eroding - someone is taking real market share or pricing power is fading across multiple cycles; (3) the valuation has gone completely insane and the market is pricing a perfect outcome across an implausible timeframe. No single signal is enough on its own. But when two or three show up together? Time to reduce or exit, regardless of how much you love the story.
PolyMarket Investment, Research Team, September 2025